Document is current
Any future updates will be listed below
-
Authors
Candeloro, Raffaella https://orcid.org/0009-0003-7895-7996
Laudisi, Michele
Ferri, Caterina
Baldi, Eleonora
Negri, Giovanna
Ghisellini, Sara
Pugliatti, Maura
Castellazzi, Massimiliano
-
Funding
Funding for this research was provided by:
Università degli Studi di Ferrara
- License Information
-
More Information
Article History
Received: 9 January 2026
Revised: 26 February 2026
Accepted: 1 March 2026
First Online: 9 March 2026
Declarations
:
: R.C. reports no disclosures. M.L. has received speaking honoraria from Novartis. C.F. has received travel grants and/or attended conferences upon invitation from Merck, Biogen, Sanofi, Novartis, and Alexion, and has received speaking honoraria from Novartis, Sanofi Genzyme, and AstraZeneca. E.L. has received travel grants from Roche, teaching fees from Biogen, Merck Serono, Novartis, Neuraxpharm, and Bristol, and served as principal investigator in a Sanofi randomized controlled trial. G.N. reports no disclosures. S.G. reports no disclosures. M.P. reports no disclosures. M.C. reports no disclosures.
